Telo Genomics Corp. 3D0A.F Stock
Telo Genomics Corp. Price Chart
Telo Genomics Corp. 3D0A.F Financial and Trading Overview
| Telo Genomics Corp. stock price | 0.11 EUR |
| Previous Close | 0.18 EUR |
| Open | 0.16 EUR |
| Bid | 0.16 EUR x N/A |
| Ask | 0.22 EUR x N/A |
| Day's Range | 0.16 - 0.16 EUR |
| 52 Week Range | 0.14 - 0.31 EUR |
| Volume | 25K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 12.36M EUR |
| Beta (5Y Monthly) | 1.96681 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3D0A.F Valuation Measures
| Enterprise Value | 10.02M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 11.642857 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.848 |
Trading Information
Telo Genomics Corp. Stock Price History
| Beta (5Y Monthly) | 1.96681 |
| 52-Week Change | -6.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.31 EUR |
| 52 Week Low | 0.14 EUR |
| 50-Day Moving Average | 0.17 EUR |
| 200-Day Moving Average | 0.2 EUR |
3D0A.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 71.16M |
| Float | 53.89M |
| Short Ratio | N/A |
| % Held by Insiders | 6.65% |
| % Held by Institutions | 1.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.17% |
| Return on Equity (ttm) | -129.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2603877 EUR |
| Net Income Avi to Common (ttm) | -2619131 EUR |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 727.58K EUR |
| Total Cash Per Share (mrq) | 0.01 EUR |
| Total Debt (mrq) | 40K EUR |
| Total Debt/Equity (mrq) | 4.9 EUR |
| Current Ratio (mrq) | 7.173 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2790161 EUR |
| Levered Free Cash Flow (ttm) | -1568996 EUR |
Profile of Telo Genomics Corp.
| Country | Germany |
| State | ON |
| City | Toronto |
| Address | MaRS Centre |
| ZIP | M5G 1L7 |
| Phone | N/A |
| Website | https://www.telodx.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncogenic and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves healthcare professionals, drug developers, and clinical researchers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.
Q&A For Telo Genomics Corp. Stock
What is a current 3D0A.F stock price?
Telo Genomics Corp. 3D0A.F stock price today per share is 0.11 EUR.
How to purchase Telo Genomics Corp. stock?
You can buy 3D0A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Telo Genomics Corp.?
The stock symbol or ticker of Telo Genomics Corp. is 3D0A.F.
Which industry does the Telo Genomics Corp. company belong to?
The Telo Genomics Corp. industry is Diagnostics & Research.
How many shares does Telo Genomics Corp. have in circulation?
The max supply of Telo Genomics Corp. shares is 93.05M.
What is Telo Genomics Corp. Price to Earnings Ratio (PE Ratio)?
Telo Genomics Corp. PE Ratio is now.
What was Telo Genomics Corp. earnings per share over the trailing 12 months (TTM)?
Telo Genomics Corp. EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Telo Genomics Corp. company belong to?
The Telo Genomics Corp. sector is Healthcare.